USANA Health Sciences (NYSE:USNA) Releases Quarterly Earnings Results, Beats Estimates By $0.15 EPS

Posted by George Bondi on Feb 26th, 2025

USANA Health Sciences (NYSE:USNA – Get Free Report) released its earnings results on Tuesday. The company reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.49 by $0.15, Zacks reports. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The firm had revenue of $213.61 million during the quarter, compared to the consensus estimate of $208.82 million. USANA Health Sciences updated its FY 2025 guidance to 2.350-3.000 EPS.

USANA Health Sciences Trading Up 8.6 %

USANA Health Sciences stock opened at $34.70 on Wednesday. The firm has a market cap of $661.38 million, a PE ratio of 12.11, a P/E/G ratio of 0.93 and a beta of 0.87. The stock’s 50 day simple moving average is $33.65 and its two-hundred day simple moving average is $36.64. USANA Health Sciences has a 12 month low of $30.13 and a 12 month high of $50.32.

Analysts Set New Price Targets

Several analysts have commented on USNA shares. StockNews.com cut shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. Sidoti downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th. Finally, DA Davidson increased their price target on USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research report on Thursday, January 2nd.

Get Our Latest Analysis on USANA Health Sciences

About USANA Health Sciences

(Get Free Report)

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.